These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6330018)

  • 1. Antimycotic activity of BAY N 7133 in animal experiments.
    Plempel M
    J Antimicrob Chemother; 1984 May; 13(5):447-63. PubMed ID: 6330018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
    Polak A
    Chemotherapy; 1987; 33(5):381-95. PubMed ID: 2822362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice.
    Polak A; Scholer HJ; Wall M
    Chemotherapy; 1982; 28(6):461-79. PubMed ID: 6297858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy for systemic mycosis.
    Polak A
    Infection; 1989; 17(4):203-9. PubMed ID: 2548963
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
    Troke PF; Andrews RJ; Marriott MS; Richardson K
    J Antimicrob Chemother; 1987 May; 19(5):663-70. PubMed ID: 3038824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical antimycotic activity of SDZ 89-485: a new orally and topically effective triazole.
    Schaude M; Petranyi G; Ackerbauer H; Meingassner JG; Mieth H
    J Med Vet Mycol; 1990; 28(6):445-54. PubMed ID: 2093117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Commonly used antifungal agents in the treatment of systemic mycoses].
    Berenguer Berenguer J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models.
    Van Cutsem J; Van Gerven F; Janssen PA
    Rev Infect Dis; 1987; 9 Suppl 1():S15-32. PubMed ID: 3027843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
    Hector RF; Yee E
    Antimicrob Agents Chemother; 1990 Mar; 34(3):448-54. PubMed ID: 2159257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in-vivo activity of an antifungal antibiotic, benanomicin A, in comparison with amphotericin B and fluconazole.
    Ohtsuka K; Watanabe M; Orikasa Y; Inouye S; Uchida K; Yamaguchi H; Kondo S; Takeuchi T
    J Antimicrob Chemother; 1997 Jan; 39(1):71-7. PubMed ID: 9044030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral, topical and parenteral antifungal treatment with itraconazole in normal and in immunocompromised animals.
    Van Cutsem J
    Mycoses; 1989; 32 Suppl 1():14-34. PubMed ID: 2561183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In-vitro and in-vivo activity of itraconazole].
    Van Cutsem J
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():5-8. PubMed ID: 1663204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimycotic therapy of experimental infections caused by dematiaceous fungi.
    Polak A
    Sabouraudia; 1984; 22(4):279-89. PubMed ID: 6095469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
    Hata K; Kimura J; Miki H; Toyosawa T; Moriyama M; Katsu K
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2243-7. PubMed ID: 8891122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of experimental murine aspergillosis with BAY n7133.
    Graybill JR; Kaster SR; Drutz DJ
    J Infect Dis; 1983 Nov; 148(5):898-906. PubMed ID: 6313822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of SM-4470, a new imidazole derivative, against experimental fungal infections.
    Ichise K; Tanio T; Saji I; Okuda T
    Antimicrob Agents Chemother; 1986 Sep; 30(3):366-9. PubMed ID: 3777903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current therapy of pulmonary and disseminated fungal diseases.
    Stamm AM; Dismukes WE
    Chest; 1983 Jun; 83(6):911-7. PubMed ID: 6303713
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy for the systemic mycoses: the prelude to ketoconazole.
    Utz JP
    Rev Infect Dis; 1980; 2(4):625-32. PubMed ID: 6255542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-fluorocytosine in the treatment of mycotic infections.
    Vandevelde AG; Mauceri AA; Johnson JE
    Ann Intern Med; 1972 Jul; 77(1):43-51. PubMed ID: 4559539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.